Circulating Damage Marker Profiles Support a Neuroprotective Effect of Erythropoietin in Ischemic Stroke Patients

The German Multicenter EPO Stroke Trial, which investigated safety and efficacy of erythropoietin (EPO) treatment in ischemic stroke, was formally declared a negative study. Exploratory subgroup analysis, however, revealed that patients not receiving thrombolysis most likely benefited from EPO durin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ehrenreich, Hannelore, Kästner, Anne, Weissenborn, Karin, Streeter, Jackson, Sperling, Swetlana, Wang, Kevin K, Worthmann, Hans, Hayes, Ronald L, von Ahsen, Nico, Kastrup, Andreas, Jeromin, Andreas, Herrmann, Manfred
Format: Artigo
Sprache:Inglês
Veröffentlicht: ScholarOne 2011
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3321813/
https://ncbi.nlm.nih.gov/pubmed/21912808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2011.00259
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge